Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Revenue | 44.88bn | 39.89bn | 35.63bn | 33.40bn | 27.03bn |
| Cost of revenue | 26.84bn | 24.92bn | 22.38bn | 21.38bn | 16.04bn |
| Gross profit | 18.03bn | 175m | 13.26bn | 12.02bn | — |
| Selling, general and administrative | 8.12bn | 87m | 6.46bn | 5.73bn | 4.94bn |
| Operating income | 3.01bn | 26m | 2.40bn | 2.65bn | 2.87bn |
| Pre-tax income | −941m | −3m | 352m | 1.02bn | 1.85bn |
| Income tax | 425m | 6m | 183m | 346m | 590m |
| Net income | −1.37bn | −9m | 169m | 675m | 1.26bn |
| Earnings per share | −3.14 | −2.10 | 0.92 | 3.69 | 6.89 |
| Earnings per share, diluted | −3.14 | −0.02 | 0.91 | 3.64 | 6.73 |
| Metric | Aug 19, 2026 | Aug 18, 2026 | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 4.10bn | 5.00bn | 4.11bn | 3.65bn | 3.78bn | — |
| Receivables | — | — | 12.65bn | 14.84bn | 14.10bn | 14.62bn | — | — |
| Inventory | — | — | 2.89bn | 46m | 3.39bn | 1.94bn | — | — |
| Current assets | — | — | 24.85bn | 310m | 24.21bn | 22.32bn | — | — |
| Property, plant and equipment | — | — | 43.48bn | 455m | 32.21bn | 22.31bn | — | — |
| Total assets | — | — | 90.67bn | 83.18bn | 70.98bn | 57.40bn | — | — |
| Current liabilities | — | — | 33.74bn | 27.66bn | 23.63bn | 22.06bn | — | — |
| Short-term debt | — | — | 15.40bn | 7.15bn | 6.67bn | 5.71bn | — | — |
| Long-term debt | — | — | 23.21bn | 28.22bn | 23.35bn | 15.82bn | — | — |
| Total liabilities | — | — | 71.74bn | 737m | 52.91bn | 42.26bn | — | — |
| Equity | — | — | 18.93bn | 16.72bn | 15.35bn | 15.15bn | 14.48bn | 13.17bn |
| Metric | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|---|
| Operating cash flow | 7.18bn | 8.65bn | 5.93bn | 8.11bn | 2.24bn |
| Depreciation and amortisation | 7.27bn | 66m | 4.77bn | 3.97bn | 3.28bn |
| Share-based compensation | 56m | 2m | 7m | 16m | 23m |
| Capital expenditure | 11.96bn | 130m | 11.12bn | 11.62bn | 6.80bn |
| Investing cash flow | −12.91bn | −144m | −12.46bn | −13.77bn | −7.59bn |
| Financing cash flow | 5.16bn | 4.73bn | 7.44bn | 4.94bn | 4.17bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)